Literature DB >> 29698571

Low-Dose Interleukin-2 for Refractory Autoimmune Hepatitis.

Tiong Y Lim1, Marc Martinez-Llordella1, Elisavet Kodela1, Elisabeth Gray1, Michael A Heneghan1, Alberto Sanchez-Fueyo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29698571     DOI： 10.1002/hep.30059

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  21 in total

Review 1.  Exploring the Pathogenic Role and Therapeutic Implications of Interleukin 2 in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2020-08-24       Impact factor: 3.199

Review 2.  Immune Inhibitory Properties and Therapeutic Prospects of Transforming Growth Factor-Beta and Interleukin 10 in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2021-04-09       Impact factor: 3.199

Review 3.  Regulatory T cells in autoimmune hepatitis: an updated overview.

Authors:  Maria Serena Longhi; Giorgina Mieli-Vergani; Diego Vergani
Journal:  J Autoimmun       Date:  2021-02-27       Impact factor: 7.094

Review 4.  Interleukin-2 and regulatory T cells in rheumatic diseases.

Authors:  Antonios G A Kolios; George C Tsokos; David Klatzmann
Journal:  Nat Rev Rheumatol       Date:  2021-11-02       Impact factor: 20.543

5.  IL-2 therapy preferentially expands adoptively transferred donor-specific Tregs improving skin allograft survival.

Authors:  Kulachelvy Ratnasothy; Jacintha Jacob; Sim Tung; Dominic Boardman; Robert Ian Lechler; Alberto Sanchez-Fueyo; Marc Martinez-Llordella; Giovanna Lombardi
Journal:  Am J Transplant       Date:  2019-03-15       Impact factor: 8.086

Review 6.  Novel Diagnostic and Therapeutic Strategies in Juvenile Autoimmune Hepatitis.

Authors:  Marco Sciveres; Silvia Nastasio; Giuseppe Maggiore
Journal:  Front Pediatr       Date:  2019-09-20       Impact factor: 3.418

Review 7.  Clinical management of autoimmune hepatitis.

Authors:  Simon Pape; Christoph Schramm; Tom Jg Gevers
Journal:  United European Gastroenterol J       Date:  2019-08-25       Impact factor: 4.623

Review 8.  Mechanisms of Immune Tolerance in Liver Transplantation-Crosstalk Between Alloreactive T Cells and Liver Cells With Therapeutic Prospects.

Authors:  Hong Lei; Petra Reinke; Hans-Dieter Volk; Yi Lv; Rongqian Wu
Journal:  Front Immunol       Date:  2019-11-19       Impact factor: 7.561

9.  Profiling the patient with autoimmune hepatitis on calcineurin inhibitors: a real-world-experience.

Authors:  Simon Pape; Frederik Nevens; Chris Verslype; Caroline Mertens; Joost P H Drenth; Eric T T L Tjwa
Journal:  Eur J Gastroenterol Hepatol       Date:  2020-06       Impact factor: 2.586

10.  IL-33 drives the production of mouse regulatory T cells with enhanced in vivo suppressive activity in skin transplantation.

Authors:  Kento Kawai; Masateru Uchiyama; Joanna Hester; Fadi Issa
Journal:  Am J Transplant       Date:  2020-09-15       Impact factor: 9.369
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.